AAV gene therapy continues to woo investors

被引：0
|
作者：
Barbara Cassasus
机构：
来源：
Nature Biotechnology | 2014年 / 32卷 / 4期
关键词：
D O I：
10.1038/nbt0414-302a
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：302 / 302
相关论文
共 50 条
  • [31] Tailoring the AAV vector capsid for gene therapy
    L H Vandenberghe
    J M Wilson
    G Gao
    Gene Therapy, 2009, 16 : 311 - 319
  • [32] AAV-mediated gene therapy for hemophilia
    Couto, LB
    Pierce, GF
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2003, 5 (05) : 517 - 523
  • [33] Gene therapy of feline gangliosidosis with AAV vectors
    Martin, Douglas R.
    Baker, Henry J.
    Cox, Nancy R.
    Cachon-Gonzalez, Begona
    Cox, Timothy M.
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S14 - S14
  • [34] Evaluating AAV vectors for HHT gene therapy
    Liang, R.
    Press, K.
    Gonzalez, T.
    Asokan, A.
    Su, H.
    ANGIOGENESIS, 2023, 26 (01) : S4 - S4
  • [35] AAV gene therapy and clinical applications: an update
    Petry, Harald
    HUMAN GENE THERAPY, 2009, 20 (11) : 1352 - 1353
  • [36] AAV-Mediated Gene Therapy for Atherosclerosis
    Lehrke, Michael
    Lebherz, Corinna
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
  • [37] AAV-mediated gene therapy for fALS
    Cappella, M.
    Cohen-Tannoudji, M.
    Marais, T.
    Astord, S.
    Besse, A.
    Giroux, B.
    Barkats, M.
    Biferi, M. G.
    HUMAN GENE THERAPY, 2018, 29 (12) : A109 - A109
  • [38] AAV gene therapy for liver metastatic cancer
    Xu, RA
    Sun, K
    Krissansen, GW
    Fung, PW
    Xu, S
    Xiao, WD
    Shi, J
    Fan, ST
    MOLECULAR THERAPY, 2004, 9 : S237 - S237
  • [39] Engineering AAV receptor footprints for gene therapy
    Madigan, Victoria J.
    Asokan, Aravind
    CURRENT OPINION IN VIROLOGY, 2016, 18 : 89 - 96
  • [40] Evading and overcoming AAV neutralization in gene therapy
    Earley, Joseph
    Piletska, Elena
    Ronzitti, Giuseppe
    Piletsky, Sergey
    TRENDS IN BIOTECHNOLOGY, 2023, 41 (06) : 836 - 845
12345